These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 33728167)

  • 1. Intensive Care Resources and 60-Day Survival of Critically-Ill COVID-19 Patients.
    Lang CN; Zotzmann V; Schmid B; Berchtold-Herz M; Utzolino S; Biever P; Duerschmied D; Bode C; Wengenmayer T; Staudacher DL
    Cureus; 2021 Feb; 13(2):e13210. PubMed ID: 33728167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and Risk Factors for Intensive Care Unit Cardiac Arrest in Critically Ill Patients with COVID-19-A Retrospective Study.
    Roedl K; Söffker G; Wichmann D; Boenisch O; de Heer G; Burdelski C; Frings D; Sensen B; Nierhaus A; Westermann D; Kluge S; Jarczak D
    J Clin Med; 2021 May; 10(10):. PubMed ID: 34069530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structured ICU resource management in a pandemic is associated with favorable outcome in critically ill COVID‑19 patients.
    Klein SJ; Bellmann R; Dejaco H; Eschertzhuber S; Fries D; Furtwängler W; Gasteiger L; Hasibeder W; Helbok R; Hochhold C; Hofer S; Kirchmair L; Krismer C; Ladner E; Lehner GF; Mathis S; Mayr A; Mittermayr M; Peer A; Preuß Hernández C; Reitter B; Ströhle M; Swoboda M; Thomé C; Joannidis M
    Wien Klin Wochenschr; 2020 Nov; 132(21-22):653-663. PubMed ID: 33170333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study.
    Schmidt M; Hajage D; Lebreton G; Monsel A; Voiriot G; Levy D; Baron E; Beurton A; Chommeloux J; Meng P; Nemlaghi S; Bay P; Leprince P; Demoule A; Guidet B; Constantin JM; Fartoukh M; Dres M; Combes A; ;
    Lancet Respir Med; 2020 Nov; 8(11):1121-1131. PubMed ID: 32798468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
    Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H
    Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of critically ill coronavirus disease 2019 patients requiring kidney replacement therapy: A retrospective cohort study.
    Braunsteiner J; Jarczak D; Schmidt-Lauber C; Boenisch O; de Heer G; Burdelski C; Frings D; Sensen B; Nierhaus A; Hoxha E; Huber TB; Wichmann D; Kluge S; Fischer M; Roedl K
    Front Med (Lausanne); 2022; 9():1027586. PubMed ID: 36341239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracorporeal Membrane Oxygenation (ECMO) in Critically Ill Patients with Coronavirus Disease 2019 (COVID-19) Pneumonia and Acute Respiratory Distress Syndrome (ARDS).
    Ma X; Liang M; Ding M; Liu W; Ma H; Zhou X; Ren H
    Med Sci Monit; 2020 Aug; 26():e925364. PubMed ID: 32759887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospital Resources May Be an Important Aspect of Mortality Rate among Critically Ill Patients with COVID-19: The Paradigm of Greece.
    Routsi C; Magira E; Kokkoris S; Siembos I; Vrettou C; Zervakis D; Ischaki E; Malahias S; Sigala I; Asimakos A; Daidou T; Kaltsas P; Douka E; Sotiriou A; Markaki V; Temberikidis P; Koroneos A; Politis P; Mastora Z; Dima E; Tsoutsouras T; Papahatzakis I; Gioni P; Strilakou A; Maragouti A; Mizi E; Kanavou A; Sarri A; Gavrielatou E; Mentzelopoulos S; Kalomenidis I; Papastamopoulos V; Kotanidou A; Zakynthinos S
    J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33233686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical Illness Due to Covid-19: A Description of the Surge in a Single Center in Sioux Falls.
    Jamous F; Meyer N; Buus D; Ateeli H; Taggart K; Hanson T; Alzoubaidi M; Nazir J; Devasahayam J
    S D Med; 2020 Jul; 73(7):312-317. PubMed ID: 32805781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 Induced Acute Respiratory Distress Syndrome-A Multicenter Observational Study.
    Herrmann J; Adam EH; Notz Q; Helmer P; Sonntagbauer M; Ungemach-Papenberg P; Sanns A; Zausig Y; Steinfeldt T; Torje I; Schmid B; Schlesinger T; Rolfes C; Reyher C; Kredel M; Stumpner J; Brack A; Wurmb T; Gill-Schuster D; Kranke P; Weismann D; Klinker H; Heuschmann P; Rücker V; Frantz S; Ertl G; Muellenbach RM; Mutlak H; Meybohm P; Zacharowski K; Lotz C
    Front Med (Lausanne); 2020; 7():599533. PubMed ID: 33392222
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dynamic measurement of volume of atelectasis area in the evaluation of the prognosis of patients with moderate-to-severe acute respiratory distress syndrome].
    Lu X; Han Y; Gao X; Wang F; Xu L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Sep; 32(9):1056-1060. PubMed ID: 33081890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and outcomes of critically ill COVID-19 patients in Tokyo: a single-center observational study from the first wave.
    Banno A; Hifumi T; Okamoto H; Masaki M; Seki K; Isokawa S; Otani N; Hayashi K; Ishimatsu S
    BMC Infect Dis; 2021 Feb; 21(1):163. PubMed ID: 33563218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case of Extracorporeal Membrane Oxygenation as a Salvage Therapy for COVID-19-Associated Severe Acute Respiratory Distress Syndrome: Mounting Evidence.
    Rajdev K; Farr LA; Saeed MA; Hooten R; Baus J; Boer B
    J Investig Med High Impact Case Rep; 2020; 8():2324709620957778. PubMed ID: 32911986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Significance of Timing of Intubation in Critically Ill Patients with COVID-19: A Multi-Center Retrospective Study.
    Lee YH; Choi KJ; Choi SH; Lee SY; Kim KC; Kim EJ; Lee J
    J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32887462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Venovenous Extracorporeal Membrane Oxygenation in Critically-Ill Patients With COVID-19.
    Jozwiak M; Chiche JD; Charpentier J; Ait Hamou Z; Jaubert P; Benghanem S; Dupland P; Gavaud A; Péne F; Cariou A; Mira JP; Nguyen LS
    Front Med (Lausanne); 2020; 7():614569. PubMed ID: 33363190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracorporeal membrane oxygenation for critically ill patients with coronavirus-associated disease 2019: an updated perspective of the European experience.
    Marullo AG; Cavarretta E; Biondi Zoccai G; Mancone M; Peruzzi M; Piscioneri F; Sartini P; Versaci F; Morelli A; Miraldi F; Frati G
    Minerva Cardioangiol; 2020 Oct; 68(5):368-372. PubMed ID: 32336080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and outcomes of coronavirus disease 2019 (COVID-19) in critically ill pediatric patients admitted to the intensive care unit: A multicenter retrospective cohort study.
    Alfraij A; Bin Alamir AA; Al-Otaibi AM; Alsharrah D; Aldaithan A; Kamel AM; Almutairi M; Alshammari S; Almazyad M; Macarambon JM; Alghounaim M
    J Infect Public Health; 2021 Feb; 14(2):193-200. PubMed ID: 33486375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracorporeal membrane oxygenation in the management of critically ill patients with coronavirus disease 2019: A narrative review.
    Pleșoianu AF; Pleșoianu CE; Bararu-Bojan Bararu I; Vlădeanu Apăvăloaei MC; Bojan A; Țăruș A; Tinică G
    Exp Ther Med; 2021 Nov; 22(5):1296. PubMed ID: 34630651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination treatment of short-course systemic corticosteroid and favipiravir in a successfully treated case of critically ill COVID-19 pneumonia with COPD.
    Inoue H; Jinno M; Ohta S; Kishino Y; Kawahara T; Mikuni H; Sato H; Yamamoto M; Sato Y; Onitsuka C; Goto Y; Ikeda H; Sato H; Uno T; Uchida Y; Kimura T; Miyata Y; Hirai K; Homma T; Watanabe Y; Kusumoto S; Suzuki S; Tokimatsu I; Tanaka A; Sagara H
    Respir Med Case Rep; 2020; 31():101200. PubMed ID: 32868989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
    Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K
    J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.